ES / EN
- July 13, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba

Favorable results of Cuban COVID-19 vaccine candidate

Developed by the Havana Center for Genetic Engineering and Biotechnology (CIGB), the Abdala vaccine candidate was evaluated days ago by an independent committee for the analysis of the data from its study in humans.

by
  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
January 27, 2021
in Cuba
0
Cuban Abdala vaccine candidate against COVID-19. Photo: Agencia Cubana de Noticias (ACN).

Cuban Abdala vaccine candidate against COVID-19. Photo: Agencia Cubana de Noticias (ACN).

The Abdala vaccine candidate, one of the four Cuban COVID-19 vaccines currently in clinical trial, is showing favorable results in terms of its safety and immunogenicity, according to the official media.

Developed by the Havana Center for Genetic Engineering and Biotechnology (CIGB), the Abdala vaccine candidate was evaluated days ago by an independent committee for the analysis of the data from its study in humans, as confirmed on social networks by Dr. Eduardo Martínez, president of the Biotechnology and Pharmaceutical Industries (BioCubaFarma) Business Group, quoted by Prensa Latina (PL) news agency.

Meanwhile, the CIGB itself affirmed on Twitter that the vaccine candidate “has had constant monitoring, supervision and evaluation.” This supervision is carried out by specialized agencies, including the National Regulatory Center for Medicines and Medical Equipment, “always with favorable results,” Granma daily highlighted.

#Abdala, desarrollado por el Centro de Ingeniería Genética y Biotecnología, y que se aplicará por vía intramuscular, ha tenido constante monitoreo, supervisión y evaluación.https://t.co/e1YQEb516c

— CIGBCuba (@CIGBCuba) January 26, 2021

Abdala began on December 2 phase I of the clinical trial with 200 volunteers at the Saturnino Lora Hospital, in the province of Santiago de Cuba. The study also involves more than 40 health professionals, including doctors, nurses and laboratory workers, and at the close of this first moment it is scheduled for February 16.

This vaccine is administered intramuscularly, unlike Mambisa, also developed by the CIGB, designed for nasopharyngeal use. Both candidates have already completed the short trial cycle, “comprised on days zero, 14 and 28, and after processing the samples, they move to another longer evaluation period, zero, 28 and 56 days,” PL said.

Related Posts

Sandra Sotolongo, co-director of the “inSurGENTES” project, during an activity in the vegetable garden. Photo: Courtesy.

Insurgents, an open-air revolution

July 10, 2025
Private business on Infanta and 23rd Streets, in Vedado, Havana. Photo: AMD.

MSMEs barely growing and their slowdown hinders competition and economic dynamism

July 9, 2025
Entrance to San Juan Park, located east of Santiago.

San Juan Hill: heritage in the attic?

July 6, 2025
Headquarters of the Matanzas People’s Court, where the trial was held. Photo: Matanzas People’s Court/Facebook.

Prosecutor’s Office requests up to 9 years in prison for synthetic drug trafficking in Matanzas

June 30, 2025

“The first indications confer safety of the two molecules, with mild adverse effects,” Dr. Miladys Limonta, manager of the COVID-19 vaccines project at the scientific center, told the agency.

Cuban COVID-19 nasal vaccine concludes first phase of trials

The two CIGB projects join those of the Finlay Vaccine Institute—Soberana 01 and 02—in the advance of the research carried out on the island to achieve a vaccine against the SARS-CoV-2 coronavirus, which, in the opinion of Cuban scientific authorities, is “advancing positively.”

This is why Cuba hopes to start the emergency use of some of these vaccine candidates in the coming months—in particular Soberana 02, the most advanced in clinical trials and of which it plans to produce 100 million doses this year—and, with it, mass vaccination in the country.

  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
Tags: coronavirus in CubaCuban vaccine against COVID-19
Previous Post

January already worst month for Cubans due to coronavirus

Next Post

U.S. restrictive policies on Cuban remittances: effects on families and emerging private sector

OnCuba Staff

OnCuba Staff

OnCuba Staff

OnCuba Staff

Next Post
People connected to the internet at the entrance of a point of sale. Photo: Otmaro Rodríguez

U.S. restrictive policies on Cuban remittances: effects on families and emerging private sector

Headquarters of the Ministry of Culture, Havana, January 27, 2021. Photo: Facebook 27N

New protest at headquarters of Ministry of Culture in Havana

As for the new infections, 666 positive cases were registered and they involve all the country’s provinces, including the Isla de la Juventud Special Municipality. Photo: Otmaro Rodríguez.

Cuba reports four deaths from COVID-19, including that of a doctor in Havana

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • OFAC.S. Department of the Treasury. Photo: Marita Pérez Díaz.

    OFAC fines U.S. company over $600,000 for shipping to Cuba

    25 shares
    Share 10 Tweet 6
  • Los Palacios, land of Cuban rice harvested by Vietnamese

    15 shares
    Share 6 Tweet 4
  • Trump reinstates hard-line Cuba embargo as Havana condemns US measure as “criminal”

    33 shares
    Share 13 Tweet 8
  • Lester Lescay: “I left Cuba because I didn’t want to spend my youth there.”

    19 shares
    Share 8 Tweet 5
  • San Juan Hill: heritage in the attic?

    15 shares
    Share 6 Tweet 4

Most Commented

  • Photo: Kaloian.

    Private sector and tourism in Cuba. Why not?

    12 shares
    Share 5 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}